one. the day by day dose, potency and characteristics of a complete agonist or combined agonist/antagonist the affected person continues to be having previously. Tend not to abruptly discontinue ROXICODONE inside of a affected individual physically dependent on opioids. When discontinuing ROXICODONE inside a physically dependent client, lit